Citius Oncology Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	2.63	3.92	0	-	0.29
Cash & Short-Term Investments	2.63	3.92	0	-	0.29
Cash Growth	2350462.50%	3504283.93%	-	-	-
Accounts Receivable	1.08	-	-	-	-
Inventory	22.66	22.29	8.27	-	-
Other Current Assets	3.05	1.33	2.7	-	0.09
Total Current Assets	29.42	27.54	10.97	7.73	0.38
Long-Term Investments	-	-	-	-	67.81
Other Long-Term Assets	71.28	73.4	73.4	40	-
Total Assets	100.7	100.94	84.37	47.73	68.19
Accounts Payable	8.88	13.23	3.71	1.29	-
Accrued Expenses	24.06	4.09	-	0.26	-
Other Current Liabilities	25.87	32.16	28.99	19.5	0.03
Total Current Liabilities	58.81	49.49	32.7	21.05	0.03
Long-Term Debt	3.8	3.8	3.8	-	-
Other Long-Term Liabilities	2.82	2.78	1.73	1.15	-
Total Long-Term Liabilities	6.62	6.59	5.53	1.15	-
Total Liabilities	65.43	56.08	38.23	22.2	0.03
Common Stock	0.01	0.01	0.01	0.01	0
Additional Paid-in Capital	131.44	108.9	85.41	43.66	-
Retained Earnings	-96.18	-64.04	-39.28	-18.13	0.35
Minority Interest	-	-	-	-	67.81
Shareholders' Equity	35.27	44.87	46.14	25.54	0.35
Total Liabilities & Equity	100.7	100.94	84.37	47.73	68.19
Total Debt	3.8	3.8	3.8	0	0
Net Cash (Debt)	-1.17	0.12	-3.8	-0	0.29
Net Cash Per Share	-0.01	0.00	-0.06	-	0.15
Book Value	35.27	44.87	46.14	25.54	0.35
Book Value Per Share	0.42	0.61	0.68	10.88	0.19
Tangible Book Value	35.27	44.87	46.14	25.54	0.35
Tangible Book Value Per Share	0.42	0.61	0.68	10.88	0.19

SEC Filings: 10-K · 10-Q